Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MOWANA™ Auto Duo

K-Number: K261266 · 2026-09-17

Decision Date2026-09-17
Product CodeFMI
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

MOWANA™ Auto Duo is the device name listed in this FDA 510(k) record. The listed applicant is PENTAMASTER MEDIQ SDN BHD. It received FDA 510(k) clearance on 2026-09-17 under 510(k) number K261266. The device is classified under product code FMI. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MOWANA™ Auto Duo?

MOWANA™ Auto Duo is a medical device that received FDA 510(k) clearance on 2026-09-17. The listed applicant is PENTAMASTER MEDIQ SDN BHD. The 510(k) number is K261266.

When did MOWANA™ Auto Duo receive FDA 510(k) clearance?

MOWANA™ Auto Duo received FDA 510(k) clearance on 2026-09-17, under 510(k) number K261266.

Who is the listed applicant for MOWANA™ Auto Duo?

The FDA 510(k) record lists PENTAMASTER MEDIQ SDN BHD as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MOWANA™ Auto Duo?

The FDA product code for MOWANA™ Auto Duo is FMI.

Related Devices (Code: FMI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑